{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:07:08Z","timestamp":1787771228848,"version":"build-2784847793"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,12,24]],"date-time":"2013-12-24T00:00:00Z","timestamp":1387843200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1038\/npp.2013.346","type":"journal-article","created":{"date-parts":[[2013,12,24]],"date-time":"2013-12-24T12:46:08Z","timestamp":1387889168000},"page":"1469-1478","source":"Crossref","is-referenced-by-count":20,"title":["HDAC Inhibitors Restore the Capacity of Aged Mice to Respond to Haloperidol through Modulation of Histone Acetylation"],"prefix":"10.1038","volume":"39","author":[{"given":"Janitza L","family":"Montalvo-Ortiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Keegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Gallardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Gerst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Tetsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuyuki","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyu","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G","family":"Csernansky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,24]]},"reference":[{"key":"BFnpp2013346_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.schres.2004.01.016","volume":"70","author":"A Basan","year":"2004","unstructured":"Basan A, Kissling W, Leucht S (2004). Valproate as an adjunct to antipsychotics for schizophrenia: a systematic review of randomized trials. Schizophr Res 70: 33\u201337.","journal-title":"Schizophr Res"},{"key":"BFnpp2013346_CR2","doi-asserted-by":"publisher","first-page":"503","DOI":"10.2217\/epi.12.41","volume":"4","author":"D Ben-Avraham","year":"2012","unstructured":"Ben-Avraham D, Muzumdar RH, Atzmon G (2012). Epigenetic genome-wide association methylation in aging and longevity. Epigenomics 4: 503\u2013509.","journal-title":"Epigenomics"},{"key":"BFnpp2013346_CR3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/nrn1809","volume":"7","author":"SN Burke","year":"2006","unstructured":"Burke SN, Barnes CA (2006). Neural plasticity in the ageing brain. Nat Rev Neurosci 7: 30\u201340.","journal-title":"Nat Rev Neurosci"},{"key":"BFnpp2013346_CR4","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.tins.2009.06.002","volume":"32","author":"DM Chuang","year":"2009","unstructured":"Chuang DM, Leng Y, Marinova Z, Kim HJ, Chiu CT (2009). Multiple roles of HDAC inhibition in neurodegenerative conditions. Trends Neurosci 32: 591\u2013601.","journal-title":"Trends Neurosci"},{"key":"BFnpp2013346_CR5","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1101\/lm.2041211","volume":"18","author":"M Darvas","year":"2011","unstructured":"Darvas M, Fadok JP, Palmiter RD (2011). Requirement of dopamine signaling in the amygdala and striatum for learning and maintenance of a conditioned avoidance response. Learn Mem 18: 136\u2013143.","journal-title":"Learn Mem"},{"key":"BFnpp2013346_CR6","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.bbagrm.2011.08.001","volume":"1819","author":"C Das","year":"2012","unstructured":"Das C, Tyler JK (2012). Histone exchange and histone modifications during transcription and aging. Biochim Biophys Acta 1819: 332\u2013342.","journal-title":"Biochim Biophys Acta"},{"key":"BFnpp2013346_CR7","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1016\/j.euroneuro.2012.11.014","volume":"23","author":"A de Bartolomeis","year":"2013","unstructured":"de Bartolomeis A, Marmo F, Filomena Buonaguro E, Rossi R, Tomasetti C, Iasevoli F (2013). Imaging brain gene expression profiles by antipsychotics: region-specific action of amisulpride on postsynaptic density transcripts compared to haloperidol. Eur Neuropsychopharmacol 23: 1516\u20131529.","journal-title":"Eur Neuropsychopharmacol"},{"key":"BFnpp2013346_CR8","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0197-4580(96)00206-0","volume":"18","author":"S Desjardins","year":"1997","unstructured":"Desjardins S, Mayo W, Vallee M, Hancock D, Le Moal M, Simon H et al (1997). Effect of aging on the basal expression of c-Fos, c-Jun, and Egr-1 proteins in the hippocampus. Neurobiol Aging 18: 37\u201344.","journal-title":"Neurobiol Aging"},{"key":"BFnpp2013346_CR9","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/1044-7431(92)90030-6","volume":"3","author":"AY Deutch","year":"1992","unstructured":"Deutch AY, Lee MC, Iadarola MJ (1992). Regionally specific effects of atypical antipsychotic drugs on striatal Fos expression: the nucleus accumbens shell as a locus of antipsychotic action. Mol Cell Neurosci 3: 332\u2013341.","journal-title":"Mol Cell Neurosci"},{"key":"BFnpp2013346_CR10","doi-asserted-by":"publisher","first-page":"71","DOI":"10.4196\/kjpp.2009.13.2.71","volume":"13","author":"SM Dong","year":"2009","unstructured":"Dong SM, Kim YG, Heo J, Ji MK, Cho JW, Kwak BS (2009). YKP1447, a novel potential atypical antipsychotic agent. Korean J Physiol Pharmacol 13: 71\u201378.","journal-title":"Korean J Physiol Pharmacol"},{"key":"BFnpp2013346_CR11","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature10849","volume":"483","author":"J Graff","year":"2012","unstructured":"Graff J, Rei D, Guan JS, Wang WY, Seo J, Hennig KM et al (2012). An epigenetic blockade of cognitive functions in the neurodegenerating brain. Nature 483: 222\u2013226.","journal-title":"Nature"},{"key":"BFnpp2013346_CR12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.tips.2008.10.010","volume":"30","author":"A Guidotti","year":"2009","unstructured":"Guidotti A, Dong E, Kundakovic M, Satta R, Grayson DR, Costa E (2009). Characterization of the action of antipsychotic subtypes on valproate-induced chromatin remodeling. Trends Pharmacol Sci 30: 55\u201360.","journal-title":"Trends Pharmacol Sci"},{"key":"BFnpp2013346_CR13","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/npp.2012.78","volume":"38","author":"I Houston","year":"2013","unstructured":"Houston I, Peter CJ, Mitchell A, Straubhaar J, Rogaev E, Akbarian S (2013). Epigenetics in the human brain. Neuropsychopharmacology 38: 183\u2013197.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2013346_CR14","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1158\/2159-8290.CD-11-0214","volume":"1","author":"RA Juergens","year":"2011","unstructured":"Juergens RA, Wrangle J, Vendetti FP, Murphy SC, Zhao M, Coleman B et al (2011). Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer. Cancer Discov 1: 598\u2013607.","journal-title":"Cancer Discov"},{"key":"BFnpp2013346_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1176\/appi.ajp.160.1.13","volume":"160","author":"S Kapur","year":"2003","unstructured":"Kapur S (2003). Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry 160: 13\u201323.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2013346_CR16","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/nrd2681","volume":"7","author":"AG Kazantsev","year":"2008","unstructured":"Kazantsev AG, Thompson LM (2008). Therapeutic application of histone deacetylase inhibitors for central nervous system disorders. Nat Rev Drug Discov 7: 854\u2013868.","journal-title":"Nat Rev Drug Discov"},{"key":"BFnpp2013346_CR17","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1042\/BJ20070779","volume":"409","author":"N Khan","year":"2008","unstructured":"Khan N, Jeffers M, Kumar S, Hackett C, Boldog F, Khramtsov N et al (2008). Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors. Biochem J 409: 581\u2013589.","journal-title":"Biochem J"},{"key":"BFnpp2013346_CR18","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/S0893-133X(02)00289-0","volume":"27","author":"O Kontkanen","year":"2002","unstructured":"Kontkanen O, Lakso M, Wong G, Castren E (2002). Chronic antipsychotic drug treatment induces long-lasting expression of fos and jun family genes and activator protein 1 complex in the rat prefrontal cortex. Neuropsychopharmacology 27: 152\u2013162.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2013346_CR19","doi-asserted-by":"publisher","first-page":"671","DOI":"10.2217\/epi.10.43","volume":"2","author":"JB Kwok","year":"2010","unstructured":"Kwok JB (2010). Role of epigenetics in Alzheimer's and Parkinson's disease. Epigenomics 2: 671\u2013682.","journal-title":"Epigenomics"},{"key":"BFnpp2013346_CR20","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1124\/pr.107.00107","volume":"60","author":"JA Lieberman","year":"2008","unstructured":"Lieberman JA, Bymaster FP, Meltzer HY, Deutch AY, Duncan GE, Marx CE et al (2008). Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection. Pharmacol Rev 60: 358\u2013403.","journal-title":"Pharmacol Rev"},{"key":"BFnpp2013346_CR21","doi-asserted-by":"crossref","unstructured":"Lonergan E, Luxenberg J, Colford J (2002). Haloperidol for agitation in dementia. Cochrane Database Syst Rev CD002852.","DOI":"10.1002\/14651858.CD003945"},{"key":"BFnpp2013346_CR22","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2174\/1874467210902010095","volume":"2","author":"B Monti","year":"2009","unstructured":"Monti B, Polazzi E, Contestabile A (2009). Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection. Curr Mol Pharmacol 2: 95\u2013109.","journal-title":"Curr Mol Pharmacol"},{"key":"BFnpp2013346_CR23","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0306-4522(01)00110-5","volume":"104","author":"CA Murphy","year":"2001","unstructured":"Murphy CA, Feldon J (2001). Interactions between environmental stimulation and antipsychotic drug effects on forebrain c-fos activation. Neuroscience 104: 717\u2013730.","journal-title":"Neuroscience"},{"key":"BFnpp2013346_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0197-4580(96)00166-2","volume":"18","author":"AH Nagahara","year":"1997","unstructured":"Nagahara AH, Handa RJ (1997). Age-related changes in c-fos mRNA induction after open-field exposure in the rat brain. Neurobiol Aging 18: 45\u201355.","journal-title":"Neurobiol Aging"},{"key":"BFnpp2013346_CR25","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.ajhg.2011.12.020","volume":"90","author":"S Numata","year":"2012","unstructured":"Numata S, Ye T, Hyde TM, Guitart-Navarro X, Tao R, Wininger M et al (2012). DNA methylation signatures in development and aging of the human prefrontal cortex. Am J Hum Genet 90: 260\u2013272.","journal-title":"Am J Hum Genet"},{"key":"BFnpp2013346_CR26","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.neulet.2010.03.041","volume":"475","author":"T Nuutinen","year":"2010","unstructured":"Nuutinen T, Suuronen T, Kauppinen A, Salminen A (2010). Valproic acid stimulates clusterin expression in human astrocytes: implications for Alzheimer's disease. Neurosci Lett 475: 64\u201368.","journal-title":"Neurosci Lett"},{"key":"BFnpp2013346_CR27","volume-title":"The Mouse Brain in Stereotaxic Coordinates, Compact","author":"G Paxinos","year":"2008","unstructured":"Paxinos G, Franklin KBJ (2008) The Mouse Brain in Stereotaxic Coordinates, Compact. Elsevier: New York."},{"key":"BFnpp2013346_CR28","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1126\/science.1186088","volume":"328","author":"S Peleg","year":"2010","unstructured":"Peleg S, Sananbenesi F, Zovoilis A, Burkhardt S, Bahari-Javan S, Agis-Balboa RC et al (2010). Altered histone acetylation is associated with age-dependent memory impairment in mice. Science 328: 753\u2013756.","journal-title":"Science"},{"key":"BFnpp2013346_CR29","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1016\/j.neurobiolaging.2010.01.009","volume":"32","author":"MR Penner","year":"2011","unstructured":"Penner MR, Roth TL, Chawla MK, Hoang LT, Roth ED, Lubin FD et al (2011). Age-related changes in Arc transcription and DNA methylation within the hippocampus. Neurobiol Aging 32: 2198\u20132210.","journal-title":"Neurobiol Aging"},{"key":"BFnpp2013346_CR30","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1038\/npp.2008.229","volume":"34","author":"A Ricobaraza","year":"2009","unstructured":"Ricobaraza A, Cuadrado-Tejedor M, Perez-Mediavilla A, Frechilla D, Del Rio J, Garcia-Osta A (2009). Phenylbutyrate ameliorates cognitive deficit and reduces tau pathology in an Alzheimer's disease mouse model. Neuropsychopharmacology 34: 1721\u20131732.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2013346_CR31","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0022-3565(25)23800-9","volume":"271","author":"GS Robertson","year":"1994","unstructured":"Robertson GS, Matsumura H, Fibiger HC (1994). Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity. J Pharmacol Exp Ther 271: 1058\u20131066.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp2013346_CR32","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/0197-0186(95)00156-5","volume":"29","author":"J Semba","year":"1996","unstructured":"Semba J, Sakai M, Miyoshi R, Mataga N, Fukamauchi F, Kito S (1996). Differential expression of c-fos mRNA in rat prefrontal cortex, striatum, N. accumbens and lateral septum after typical and atypical antipsychotics: an in situ hybridization study. Neurochem Int 29: 435\u2013442.","journal-title":"Neurochem Int"},{"key":"BFnpp2013346_CR33","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0197-0186(99)00009-1","volume":"34","author":"J Semba","year":"1999","unstructured":"Semba J, Sakai MW, Suhara T, Akanuma N (1999). Differential effects of acute and chronic treatment with typical and atypical neuroleptics on c-fos mRNA expression in rat forebrain regions using non-radioactive in situ hybridization. Neurochem Int 34: 269\u2013277.","journal-title":"Neurochem Int"},{"key":"BFnpp2013346_CR34","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1073\/pnas.0510341103","volume":"103","author":"MV Simonini","year":"2006","unstructured":"Simonini MV, Camargo LM, Dong E, Maloku E, Veldic M, Costa E et al (2006). The benzamide MS-275 is a potent, long-lasting brain region-selective inhibitor of histone deacetylases. Proc Natl Acad Sci USA 103: 1587\u20131592.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp2013346_CR35","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s00213-003-1579-7","volume":"171","author":"BE Sumner","year":"2004","unstructured":"Sumner BE, Cruise LA, Slattery DA, Hill DR, Shahid M, Henry B (2004). Testing the validity of c-fos expression profiling to aid the therapeutic classification of psychoactive drugs. Psychopharmacology (Berl) 171: 306\u2013321.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp2013346_CR36","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1002\/hup.1073","volume":"24","author":"T Suzuki","year":"2009","unstructured":"Suzuki T, Uchida H, Takeuchi H, Nakajima S, Nomura K, Tanabe A et al (2009). Augmentation of atypical antipsychotics with valproic acid. An open-label study for most difficult patients with schizophrenia. Hum Psychopharmacol 24: 628\u2013638.","journal-title":"Hum Psychopharmacol"},{"key":"BFnpp2013346_CR37","doi-asserted-by":"publisher","first-page":"e64","DOI":"10.1038\/tp.2011.61","volume":"1","author":"B Tang","year":"2011","unstructured":"Tang B, Dean B, Thomas EA (2011). Disease- and age-related changes in histone acetylation at gene promoters in psychiatric disorders. Transl Psychiatry 1: e64.","journal-title":"Transl Psychiatry"},{"key":"BFnpp2013346_CR38","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s12031-007-0006-7","volume":"32","author":"N Tanic","year":"2007","unstructured":"Tanic N, Perovic M, Mladenovic A, Ruzdijic S, Kanazir S (2007). Effects of aging, dietary restriction and glucocorticoid treatment on housekeeping gene expression in rat cortex and hippocampus-evaluation by real time RT-PCR. J Mol Neurosci 32: 38\u201346.","journal-title":"J Mol Neurosci"},{"key":"BFnpp2013346_CR39","doi-asserted-by":"publisher","first-page":"358","DOI":"10.2174\/138161210790170085","volume":"16","author":"ML Wadenberg","year":"2010","unstructured":"Wadenberg ML (2010). Conditioned avoidance response in the development of new antipsychotics. Curr Pharmaceut Des 16: 358\u2013370.","journal-title":"Curr Pharmaceut Des"},{"key":"BFnpp2013346_CR40","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1017\/S1461145706006638","volume":"10","author":"ML Wadenberg","year":"2007","unstructured":"Wadenberg ML, Wiker C, Svensson TH (2007). Enhanced efficacy of both typical and atypical antipsychotic drugs by adjunctive alpha2 adrenoceptor blockade: experimental evidence. Int J Neuropsychopharmacol 10: 191\u2013202.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFnpp2013346_CR41","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1038\/npp.2013.186","volume":"38","author":"ML Watt","year":"2013","unstructured":"Watt ML, Rorick-Kehn L, Shaw DB, Knitowski KM, Quets AT, Chesterfield AK et al (2013). The muscarinic acetylcholine receptor agonist BuTAC mediates antipsychotic-like effects via the M4 subtype. Neuropsychopharmacology 38: 2717\u20132726.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2013346_CR42","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1200\/JCO.2011.38.9411","volume":"30","author":"SE Witta","year":"2012","unstructured":"Witta SE, Jotte RM, Konduri K, Neubauer MA, Spira AI, Ruxer RL et al (2012). Randomized phase II trial of erlotinib with and without entinostat in patients with advanced non-small-cell lung cancer who progressed on prior chemotherapy. J Clin Oncol 30: 2248\u20132255.","journal-title":"J Clin Oncol"},{"key":"BFnpp2013346_CR43","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.neuroscience.2010.01.023","volume":"166","author":"C Zhao","year":"2010","unstructured":"Zhao C, Li M (2010). c-Fos identification of neuroanatomical sites associated with haloperidol and clozapine disruption of maternal behavior in the rat. Neuroscience 166: 1043\u20131055.","journal-title":"Neuroscience"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp2013346.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2013346","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2013346.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T09:02:15Z","timestamp":1746090135000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp2013346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,24]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["BFnpp2013346"],"URL":"https:\/\/doi.org\/10.1038\/npp.2013.346","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,24]]}}}